Last quarter (Q3 2023), vTv Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, vTv Therapeutics's net income was $-6.65M. See vTv Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 9.00K	$ 2.02M	$ 4.00M	$ 6.41M	$ 2.76M	$ 12.43M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ -159.00K	$ 2.02M	$ 4.00M	-	-	-
Operating Expense	$ 14.44M	$ 24.56M	$ 25.67M	$ 18.27M	$ 23.66M	$ 32.26M
Operating Income	$ -27.31M	$ -22.54M	$ -21.66M	$ -11.85M	$ -20.89M	$ -19.82M
Net Non Operating Interest Income Expense	$ 524.00K	$ 337.00K	$ -11.00K	$ -680.00K	$ -1.77M	$ -3.23M
Other Income Expense	$ 2.37M	$ 3.62M	$ -4.06M	$ -270.00K	$ 828.00K	$ -592.00K
Pretax Income	$ -27.61M	$ -24.87M	$ -17.62M	$ -12.80M	$ -21.84M	$ -23.64M
Tax Provision	-	$ 200.00K	$ 115.00K	$ 0.00	$ 100.00K	$ 200.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -21.52M	$ -19.16M	$ -12.99M	$ -8.50M	$ -17.91M	$ -8.65M
Basic EPS	$ -0.38	$ -0.26	$ -0.21	$ -0.18	$ -0.59	$ -0.69
Diluted EPS	$ -0.28	$ -0.26	$ -0.21	$ -0.18	$ -0.59	$ -0.69
Basic Average Shares	$ 319.33M	$ 74.88M	$ 60.73M	$ 47.14M	$ 30.29M	$ 12.45M
Diluted Average Shares	$ 319.33M	$ 74.88M	$ 60.73M	$ 47.14M	$ 30.29M	$ 12.45M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ -0.37	-
Reported Normalized Diluted E P S	-	-	-	$ -0.17	$ -0.37	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 14.44M	$ 24.56M	$ 25.67M	$ 18.27M	$ 23.66M	$ 32.26M
Net Income From Continuing And Discontinued Operation	$ -21.52M	$ -19.16M	$ -12.99M	$ -8.50M	$ -13.04M	$ -7.91M
Normalized Income	$ -8.24M	$ -19.65M	-	$ -8.50M	$ -13.04M	$ -7.91M
Interest Expense	-	-	-	$ 692.00K	$ 1.83M	$ 3.29M
EBIT	$ -27.86M	$ -24.86M	$ -17.61M	$ -12.11M	$ -20.01M	$ -20.36M
EBITDA	$ -19.25M	$ -24.77M	$ -17.52M	$ -12.02M	$ -19.97M	$ -20.14M

Currency in USD

vTv Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing